Literature DB >> 29460266

Increased Levels of Rictor Prevent Mutant Huntingtin-Induced Neuronal Degeneration.

Jordi Creus-Muncunill1,2,3, Laura Rué1,2,3,4, Rafael Alcalá-Vida1,2,3, Raquel Badillos-Rodríguez1,2,3, Joan Romaní-Aumedes1, Sonia Marco5, Jordi Alberch1,2,3, Isabel Perez-Otaño5, Cristina Malagelada1, Esther Pérez-Navarro6,7,8.   

Abstract

Rictor associates with mTOR to form the mTORC2 complex, which activity regulates neuronal function and survival. Neurodegenerative diseases are characterized by the presence of neuronal dysfunction and cell death in specific brain regions such as for example Huntington's disease (HD), which is characterized by the loss of striatal projection neurons leading to motor dysfunction. Although HD is caused by the expression of mutant huntingtin, cell death occurs gradually suggesting that neurons have the capability to activate compensatory mechanisms to deal with neuronal dysfunction and later cell death. Here, we analyzed whether mTORC2 activity could be altered by the presence of mutant huntingtin. We observed that Rictor levels are specifically increased in the striatum of HD mouse models and in the putamen of HD patients. Rictor-mTOR interaction and the phosphorylation levels of Akt, one of the targets of the mTORC2 complex, were increased in the striatum of the R6/1 mouse model of HD suggesting increased mTORC2 signaling. Interestingly, acute downregulation of Rictor in striatal cells in vitro reduced mTORC2 activity, as shown by reduced levels of phospho-Akt, and increased mutant huntingtin-induced cell death. Accordingly, overexpression of Rictor increased mTORC2 activity counteracting cell death. Furthermore, normalization of endogenous Rictor levels in the striatum of R6/1 mouse worsened motor symptoms suggesting an induction of neuronal dysfunction. In conclusion, our results suggest that increased Rictor striatal levels could counteract neuronal dysfunction induced by mutant huntingtin.

Entities:  

Keywords:  Akt; Raptor; S6K; Striatum; mTOR

Mesh:

Substances:

Year:  2018        PMID: 29460266     DOI: 10.1007/s12035-018-0956-5

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  75 in total

1.  Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease.

Authors:  Albert Giralt; Ana Saavedra; Olga Carretón; Xavier Xifró; Jordi Alberch; Esther Pérez-Navarro
Journal:  Hum Mol Genet       Date:  2011-08-11       Impact factor: 6.150

2.  Mammalian target of rapamycin complex 1 (mTORC1) and 2 (mTORC2) control the dendritic arbor morphology of hippocampal neurons.

Authors:  Malgorzata Urbanska; Agata Gozdz; Lukasz J Swiech; Jacek Jaworski
Journal:  J Biol Chem       Date:  2012-07-18       Impact factor: 5.157

3.  Brain region- and age-dependent dysregulation of p62 and NBR1 in a mouse model of Huntington's disease.

Authors:  Laura Rué; Graciela López-Soop; Ellen Gelpi; Marta Martínez-Vicente; Jordi Alberch; Esther Pérez-Navarro
Journal:  Neurobiol Dis       Date:  2013-01-04       Impact factor: 5.996

4.  mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action.

Authors:  Ghada A Soliman; Hugo A Acosta-Jaquez; Elaine A Dunlop; Bilgen Ekim; Nicole E Maj; Andrew R Tee; Diane C Fingar
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

Review 5.  The neurology of mTOR.

Authors:  Jonathan O Lipton; Mustafa Sahin
Journal:  Neuron       Date:  2014-10-22       Impact factor: 17.173

6.  Inhibited insulin signaling in mouse hepatocytes is associated with increased phosphatidic acid but not diacylglycerol.

Authors:  Chongben Zhang; Gwen Hwarng; Daniel E Cooper; Trisha J Grevengoed; James M Eaton; Viswanathan Natarajan; Thurl E Harris; Rosalind A Coleman
Journal:  J Biol Chem       Date:  2014-12-15       Impact factor: 5.157

7.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.

Authors:  Brinda Ravikumar; Coralie Vacher; Zdenek Berger; Janet E Davies; Shouqing Luo; Lourdes G Oroz; Francesco Scaravilli; Douglas F Easton; Rainer Duden; Cahir J O'Kane; David C Rubinsztein
Journal:  Nat Genet       Date:  2004-05-16       Impact factor: 38.330

8.  Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.

Authors:  A Jennifer Morton; Dervila Glynn; Wendy Leavens; Zhiguang Zheng; Richard L M Faull; Jeremy N Skepper; James M Wight
Journal:  Neurobiol Dis       Date:  2008-12-11       Impact factor: 5.996

9.  Early down-regulation of PKCδ as a pro-survival mechanism in Huntington's disease.

Authors:  Laura Rué; Rafael Alcalá-Vida; Graciela López-Soop; Jordi Creus-Muncunill; Jordi Alberch; Esther Pérez-Navarro
Journal:  Neuromolecular Med       Date:  2013-07-30       Impact factor: 3.843

Review 10.  mTOR complexes in neurodevelopmental and neuropsychiatric disorders.

Authors:  Mauro Costa-Mattioli; Lisa M Monteggia
Journal:  Nat Neurosci       Date:  2013-10-28       Impact factor: 24.884

View more
  2 in total

Review 1.  Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration.

Authors:  Henry Querfurth; Han-Kyu Lee
Journal:  Mol Neurodegener       Date:  2021-07-02       Impact factor: 14.195

2.  Synaptic RTP801 contributes to motor-learning dysfunction in Huntington's disease.

Authors:  Núria Martín-Flores; Leticia Pérez-Sisqués; Jordi Creus-Muncunill; Mercè Masana; Sílvia Ginés; Jordi Alberch; Esther Pérez-Navarro; Cristina Malagelada
Journal:  Cell Death Dis       Date:  2020-07-30       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.